Open AccessRandomized controlled trial of trehalose: An efficient autophagic bioprotectant in the management of dry eye disease
Author(s) -
Arvind Kumar Morya,
Kanchan Solanki,
Sujeet Prakash,
Monika Samota,
Arushi Gupta
Publication year - 2021
Publication title -
taiwan journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.519
H-Index - 9
eISSN - 2211-5072
pISSN - 2211-5056
DOI - 10.4103/tjo.tjo_58_20
Subject(s) - trehalose , medicine , confidence interval , sodium hyaluronate , randomized controlled trial , ophthalmology , schirmer test , sodium fluorescein , surgery , dry eyes , fluorescein , biology , biochemistry , physics , quantum mechanics , fluorescence
To compare the therapeutic effect of sodium hyaluronate (SH)-trehalose (Trehalube, Microlabs, Bangalore, India, SH 0.1% and trehalose 3%) or SH (0.1% Hylotears, Raymed, Chandigarh, India) alone in patients with dry eye disease (DED).